AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma
by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac
Updated on: April 28,2024
0

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma
by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac
Updated on:April 28,2024
0
